• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up.
 

Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up.

Options
  • Details
BORIS DOI
10.7892/boris.125247
Date of Publication
March 15, 2018
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Emeriti, Medizinische...

Author
Piccolo, Raffaele
Universitätsklinik für Kardiologie
Stortecky, Stefan
Universitätsklinik für Kardiologie
Franzone, Anna
Universitätsklinik für Kardiologie
Siontis, Georgios
Universitätsklinik für Kardiologie
Pilgrim, Thomas
Universitätsklinik für Kardiologie
Meier, Bernhard
Emeriti, Medizinische Fakultät
Windecker, Stephan
Universitätsklinik für Kardiologie
Subject(s)

600 - Technology::610...

Series
International journal of cardiology
ISSN or ISBN (if monograph)
0167-5273
Publisher
Elsevier
Language
English
Publisher DOI
10.1016/j.ijcard.2018.01.001
PubMed ID
29338916
Uncontrolled Keywords

Embolic stroke Meta-a...

Description
BACKGROUND

Little is known regarding changes in treatment effect over time associated with patent foramen ovale (PFO) closure among patients with embolic stroke of unknown origin.

METHODS

We reconstructed Kaplan-Meier curves for stroke from individual randomized trials comparing PFO closure vs. medical therapy among patients with embolic stroke. Random effects Cox-regression analyses were performed in order to estimate hazard ratios (HRs) with 95% confidence intervals (95%CIs).

RESULTS

A total of 2531 patients enrolled across 4 randomized trials were included. PFO closure was associated with a significant reduction in the risk of stroke at longest available follow-up (HR 0.18, 95%CI 0.06 to 0.59, P=0.005). However, recurrent stroke was already significantly reduced among patients randomized to PFO closure at 1-year (HR 0.40, 95%CI 0.20 to 0.80, P=0.010), with the treatment effect remaining consistent (P-for-interaction=0.356) between 1- and 5-year (HR 0.14, 95%CI 0.05 to 0.55, P=0.005) and beyond 5-year (HR 0.20, 95%CI 0.03 to 1.19, P=0.077).

CONCLUSIONS

Among patients with embolic stroke of unknown origin, PFO closure reduces the risk of stroke compared with medical therapy, with a significant reduction in recurrences starting already within 1-year after percutaneous PFO closure.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/63307
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention.pdftextAdobe PDF276.74 KBpublisherpublished restricted
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo